My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Revista Habanera de Ciencias Médicas
On-line version ISSN 1729-519X
Abstract
HERRERA OROPESA, Yeneisis et al. Cardiovascular risk factors in patients on hemodialysis. Rev haban cienc méd [online]. 2021, vol.20, n.6, e3654. Epub Dec 10, 2021. ISSN 1729-519X.
Introduction:
Cardiovascular disease is the leading cause of death in patients with chronic kidney disease. In hypertensive patients, chronic kidney disease is the second cause of death, and systemic vascular damage has become the norm.
Objective:
To identify traditional and non-traditional cardiovascular risk factors and their association with cardiovascular disease in patients on hemodialysis.
Material and Methods:
Cross-sectional study conducted on 247 patients on chronic hemodialysis. The variables analyzed included: causes of chronic kidney disease, traditional and non-traditional cardiovascular risk factors, and cardiovascular diseases. Frequency tables and association statistics were determined by the chi-square test. The prevalence ratio (PR) was used to determine the risk of mortality. The level of statistical significance was considered to be at p value of less than 0,05 with a reliability of 95 %.
Results:
The most frequent causes of chronic kidney disease were arterial hypertension (35,6 %) and type 2 diabetes mellitus (33,1 %). Hypertensive patients were 2,63 times more likely to present cardiovascular disease than the reference group. In the case of non-traditional cardiovascular risk factors, the patients with elevated C-reactive protein were 5,19 more likely to develop cardiovascular disease, followed by those with hyperuricemia that were 3,79 more likely, and the patients with alterations in calcium and phosphorous who were 3,27 times more likely to suffer from this disease.
Conclusions:
Traditional cardiovascular risk factors are significantly related to the presence of cardiovascular disease.
Keywords : Chronic kidney disease; risk factors; cardiovascular disease, hypertensive patients.